STOCKS TELEGRAPH

Tag: EW

  • Edwards Lifesciences Corporation (EW) stock has seen a decrease of 5.74% – Here’s why?

    Edwards Lifesciences Corporation (EW) experienced a decrease of 5.74% in the aftermarket after the company announced fourth-quarter results. However, the last trading session concluded at $108.63 with a decrease of 0.79%.

    Fourth Quarter Results by EW – What’s up?

    EW reported fourth-quarter results on 26th January 2022. The company stated that they have seen a 19% increase in the 2021 sales. Not only this but Q4 sales also inclined to $1.33 billion with the growth of almost 12%. Moreover, the selling, general, and administrative expenses totaled $424 million, $339 million more than that of the previous year. In comparison to the COVID, this growth was motivated by the return of medical congresses and commercial activities. Last but not the least, the research and development expenses also increased 19 percent to $233 million.

    So what?

    EW sees even greater growth and progress in 2022. The business is optimistic about the continued spread of transcatheter-based therapies for the many structural heart patients who still require them, putting them in a good position for long-term success. As the world’s population ages and the cardiovascular disease continues to be the main cause of death, EW predicts that the chance to service patients will nearly double between now and 2028. Finally, the organization is optimistic about the possibility of a patient-centered innovation strategy to transform treatment.

    FDA Approval for Sapien 3 – More About it

    On 20th December 2021, EW announced that FDA has authorized the use of the Edwards SAPIEN 3 transcatheter valve. The FDA’s authorization of the SAPIEN 3 with Alterra is fantastic news for patients all over the world, including those who have had multiple surgeries to treat their congenital heart defects.

    Moreover, the excellent results of SAPIEN 3 with Alterra will broaden the number of patients requiring pulmonary valve replacement. Lastly, this will lead to major improvements in quality of life as well as a decrease in the number of surgeries and treatments that a congenital heart patients will require during their lifespan.

  • Early Morning Vibes: 3 Hot Stocks to Watch Before Long Weekend

    Early Morning Vibes: 3 Hot Stocks to Watch Before Long Weekend

    On February 11, American stock exchanges finished trading mostly in the green zone. The S&P 500 index rose 0.17% to 3916 points, the NASDAQ added 0.38%, the Dow Jones fell by a purely symbolic 0.02%. There were no new drivers for the movement, so investors were guided by the already familiar factors. The tech sector recovered 1.1% after falling the day before. In contrast, the energy sector fell 1.53% as part of the correction after the rally.

    Company news

    Game developer Zynga (ZNGA: + 7.4%) exceeded expectations due to strong demand for gaming entertainment and increased ad revenue.

    Home audio system maker Sonos (SONO: + 15.7%) posted strong quarterly results and strong forecasts.

    Strong reporting from Zebra Technologies (ZBRA: + 10%) reflected a rebound in SME demand for the company’s solutions.

    Today, world stock exchanges are showing mostly positive dynamics. The news background remains quite calm. Strong factors supporting optimism remain the prospects for fiscal stimulus adoption in late February or March, positive quarterly reporting, and strong corporate forecasts for 2021. At the same time, investors are worried about the overbought of some market segments, as well as the threat of the spread of new strains of coronavirus.

    The Biden administration has ordered an additional 100 million doses of Pfizer / BioNTech anticoid vaccine and another 100 million doses from Moderna. The vaccination campaign continues to accelerate. About 1.6 million vaccinations are made every day, although at the beginning of February the figure was at 1.3 million. At the current rate, it will take nine months to ensure immunity to 75% of the US population, but the vaccination procedure is accelerating. A poll of economists by the WSJ indicated an improvement in US GDP forecasts. Now, on average, the economy is expected to grow by 4.9% this year, which is 0.6% higher than the January estimates. Economists say the main reason for the positive revision of the forecast is the increase in the rate of vaccination.

    Note that on Monday, the US stock exchanges will not work, so investors today may be inclined to partially close positions. Against this background, the continuation of lateral dynamics or a slight correction is most likely.

    Technically, the S&P 500 is still in an uptrend. The broad market index is consolidating in a tight range after rising 4% last week. Resistance at the upper border of the uptrend is still a significant obstacle. The RSI indicator is forming a bearish divergence, which may lead to a short-term correction.

    Today Top Movers

    China Liberal Education Holdings (CLEU) share price jumped 79.26% to $7.26 during the early morning ‎trading session on ‎Friday after a 13G filing showed 4 Investors has stakes in the company totaling 57.17%.
    ‎
    2U Inc (TWOU) stock ascended 4.58% at $51.42 in the pre-market trading today after the company released financial and operating results for the full-year and fourth quarter ended December 31, 2020. ‎

    Denison Mines Corp (DNN) gained over 41.34% at $1.47 in pre-market ‎trading on Friday.‎ The company recently reported 2020 phoenix expansion drilling returns best results to date at Zone C.

    Top Upgrades & Downgrades

    Jefferies turned bullish on Prothena Corporation plc (PRTA), upgrading the stock to “Buy” and assigning a $30.0 price target, representing potential upside of 91.08% from Thursday’s close. 

    HubSpot Inc. (HUBS) has won the favor of Raymond James’s equity research team. The firm upgraded the shares from Outperform to Strong Buy and moved their price target to $725.0, suggesting 66.1% additional upside for the stock. 

    TransUnion (TRU) received an upgrade from analysts at Jefferies, who also set their one-year price target on the stock to $115. They changed their rating on TRU to Buy from Hold in a recently issued research note.

    Earlier Friday DA Davidson reduced its rating on NIC Inc. (EGOV) stock to Neutral from Buy and assigned the price target to $34.0. 

    BofA analysts reduced their investment ratings, saying in research reports covered by the media that its rating for TreeHouse Foods Inc. (THS) has been changed to neutral from Buy and the new price target is set at $52.

    Analysts at BofA ‎downgraded PTC Therapeutics Inc. (PTCT)’s stock to Neutral from Buy Friday.

    Latest Insider Activity

    Allegro MicroSystems Inc. (ALGM) Brown Christopher announced the sale of shares taking place on Feb 09 at $29.16 for some 12,500 shares. The total came to more than $0.36 million.

    Edwards Lifesciences Corporation (EW) CVP, Japan & Intercontinental WANG HUIMIN sold on Feb 11 a total 93,213 shares at $86.81 on average. The insider’s sale generated proceeds of almost $1.02 million.

    DXC Technology Company (DXC) Director FERNANDEZ RAUL J declared the purchase of shares taking place on Feb 10 at $25.76 for some 1,943 shares. The transaction amount was around $50060.0.

    Infrastructure and Energy Alternatives Inc. (IEA) Director Ares Management Corp bought on Feb 09 a total of 71,226 shares at $1000.00 on average. The purchase cost the insider an estimated $56.61 million.

    Important Earnings

    Top US earnings releases scheduled for today include ImmunoGen, Inc. (NASDAQ: IMGN). It will announce its Dec 2020 financial results. The company is expected to report earnings of -$0.08 per share from revenues of $40.83M in the three-month period. 

    Analysts expect Newell Brands Inc. (NASDAQ: NWL) to report a net income (adjusted) of $0.48 per share when the company releases its quarterly results shortly. Revenue for the fiscal quarter ended Dec 2020 is predicted to come in at $2.63B. 

    Dominion Energy Inc. (D), due to announce earnings before the market opens today, is expected to report earnings of $0.8 per share from revenues of $4.24B recently concluded three-month period.

  • Top 15 Best Performing Medical Device Manufacture Companies Of 2020

    Top 15 Best Performing Medical Device Manufacture Companies Of 2020

    New medical innovations are emerging day by day and are playing a major role in the health care sector. Much of the credit for these new technological innovations go to the medical devices industry. Technological advancement is continuously changing the medical devices industry. The medical devices that provide and analyze data of patients within minutes are aiding the healthcare organizations to improve patients outcomes, lower costs, and enhance efficiency.

    2020 is the year of challenges and opportunities for many industries including the medical devices industry. The medical device industry is growing with fast speed and it doesn’t seem like it is going to be slowing down anytime soon. The growth in the medical devices industry has occurred because of increasing severe disease with the increasing population. These new diseases need new treatments that can reduce the symptoms in patients. The medical devices industry is important to patients for many reasons. Medical devices companies engaged in the innovations of new technologies that are helpful for patients with chronic diseases.

    Here are the top 15 leading players in the medical devices industry you should be holding right now:

    SmileDirectClub Inc. (NASDAQ: SDC)

    SmileDirectClub Inc. (NASDAQ: SDC) last closed at $11.27, in a 52-week range of $3.64 to $21.10. Analysts have a consensus price target of $10.08. SmileDirectClub Inc. (SDC) has partnered with Meredith Corporation (MDP) to introduce Telehealth Explained. Telehealth Explained is the new platform aimed to educate consumers about the many benefits of telehealth for physical, mental, and dental health.  SmileDirectClub Inc.’s market cap has remained high, hitting $4.66 billion at the time of writing.

    CHF Solutions Inc. (CHFS)

    CHF Solutions Inc. (CHFS) stock soar by 5.85% to $0.32. CHF Solutions Inc. (CHFS) has earlier disclosed that it has received 180-extension to meet the Nasdaq minimum bid price requirement. The company has now the time since February 24, 2021, to meet all the requirements.  CHFS has earlier hosted the interactive, physician-led webinar to discuss “Precision Medicine for the Treatment of Fluid Overload in Patients with Acute Heart Failure.” CHF Solutions has a 52-weeks low and high range of $0.28 and a low range of $2.92.

    Abbott Laboratories (NYSE: ABT)

    Abbott Laboratories (NYSE: ABT) stock soar by 2.89% to $105.81. The most recent rating by Goldman, on June 01, 2020, is at a Sell. Abbott Laboratories (ABT) has earlier disclosed that it has initiated the LIFE-BTK clinical trial to evaluate the safety and effectiveness of the company’s new Esprit™ BTK Everolimus-Eluting Resorbable Scaffold System.  ABT has a 52-weeks low and high range of $61.61 and $114.19, respectively. It has a market cap of $189.80 billion at the time of writing.

    Avinger Inc. (NASDAQ: AVGR)

    Avinger Inc. (NASDAQ: AVGR) Shares headed rising, higher as much as 3.70%. The most recent rating by Ladenburg Thalmann, on March 09, 2018, is at a Buy. Avinger Inc. (AVGR) has earlier disclosed that the underwriter of its earlier revealed underwritten public offering has practiced, in full, their option to purchase an additional 1,000,000 shares of the Company’s common stock at a price of $0.47 per share. Avinger Inc.’s market capitalization has remained high, hitting $36.67 million at the time of writing.

    InspireMD Inc. (AMEX: NSPR)

    InspireMD Inc. (AMEX: NSPR) fall -7.23% after losing more than -$0.02 on Wednesday. InspireMD Inc. has disclosed that it has received the FDA approval to proceed with a pivotal study of the CGuard Carotid Stent System, CARENET-III, for prevention of stroke in patients in the United States.  The FDA approval of Investigational Device Exemption (IDE) has been proved to be useful for the company as it is now able to conduct the trial to check the potential of CGuard EPS against carotid artery disease.

    BIOLASE Inc. (NASDAQ: BIOL)

    BIOLASE Inc. (NASDAQ: BIOL) last closed at $0.30, in a 52-week range of $0.21 to $1.16. BIOLASE Inc. (BIOL) has disclosed that Todd Norbe, President and CEO, and John Beaver, COO, and CFO, will be providing an overview of the Company, as well as recent progress and achievements at the Colliers & Co.  Institutional Investor Conference on Thursday, September 10, 2020. BIOLASE Inc. has a market capitalization of $26.66 million at the time of writing.

    Stryker Corporation (NYSE: SYK)

    Stryker Corporation (NYSE: SYK) stock soar by 2.66% to $205.41. The most recent rating by Barclays, on April 13, 2020, is at an Underweight. Stryker Corporation (SYK) has earlier revealed that it will take part in the Morgan Stanley 18th Annual Virtual Global Healthcare Conference on Tuesday, September 15, 2020. This company’s market capitalization has remained high, hitting $77.31 billion at the time of writing.

    Livongo Health Inc. (NASDAQ: LVGO)

    Livongo Health Inc. (NASDAQ: LVGO) last closed at $128.03, in a 52-week range of $15.12 to $150.00. Analysts have a consensus price target of $130.41. Livongo Health Inc. (LVGO) disclosed that executives of Livongo Health and the executives from Teladoc Health will be participating in the following upcoming investor conferences. It had a trading volume of 1.72 million as compared to the average volume of 4.89 million.

    Boston Scientific Corporation (NYSE: BSX)

    Boston Scientific Corporation (NYSE: BSX) shares headed rising, higher as much as 1.49% after Boston Scientific Launches Vercise Genus™ DBS System In Europe. The most recent rating by SVB Leerink, on April 22, 2020, is at an Mkt perform. Boston Scientific Corporation (BSX) has a 52-weeks low and high range of $24.10 and $46.62, respectively. It has a market cap of $59.43 billion at the time of writing.

    Medtronic plc (NYSE: MDT)

    Medtronic plc (NYSE: MDT) rose 1.99% after gaining more than $2.08 on Wednesday. Medtronic Receives Breakthrough Device Designation from FDA, Begins Early Feasibility Study for Investigational Intrepid™ Transcatheter Valve System for the Treatment of Tricuspid Valve Regurgitation. Medtronic plc (MDT) has traded up 47.87% from its 52-weeks low and traded down -12.68% from its 52-weeks high.

    Ra Medical Systems Inc. (RMED)

    Ra Medical Systems Inc. (RMED) last closed at $0.25, in a 52-week range of $0.26 to $2.69. Ra Medical Systems to Present at H.C. Wainwright 22nd Annual Global Investment Conference on September 16. Ra Medical Systems Inc. (RMED) has traded down -2.46% from its 52-weeks low and traded down 90.57% from its 52-weeks high.

    Hancock Jaffe Laboratories Inc. (NASDAQ: HJLI)

    Hancock Jaffe Laboratories Inc. (NASDAQ: HJLI) shares were trading up 12.80% at $0.41 at the time of writing on Wednesday. Hancock Jaffe Laboratories Inc. (NASDAQ: HJLI) share price went from a low point around $0.21 to briefly over $1.03 in the past 52 weeks, though shares have since pulled back to $0.41. HJLI market cap has remained high, hitting $16.12M at the time of writing.

    Nano-X Imaging Ltd. (NASDAQ: NNOX)

    Nano-X Imaging Ltd. (NASDAQ: NNOX) shares headed rising, higher as much as 7.76% after Nanox Signs Agreement With SPI Medical for the Deployment of 630 Nanox. Its stock has fluctuated between the 52-weeks low of $20.25 and a 52-weeks high range of $43.48. NNOX has moved up 117.33% and 1.24% from its 52-weeks low and high, respectively. Its market capitalization has remained high, hitting $2.08 billion.

    Edwards Lifesciences Corporation (NYSE: EW)

    Edwards Lifesciences Corporation (NYSE: EW) rose 3.26% after gaining more than $2.68 on Wednesday. Edwards Lifesciences Corporation (EW) stock has fluctuated between the 52-weeks low of $51.51 and a 52-weeks high range of $87.79. EW has moved up 64.72% from its 52-weeks low and moved down -3.36% from its 52-weeks high, respectively. Its market capitalization has remained high, hitting $54.00 billion.

    Wright Medical Group N.V. (NASDAQ: WMGI)

    Wright Medical Group N.V. (NASDAQ: WMGI) stock drop by -0.26% to $30.30. The most recent rating by Jefferies, on December 24, 2019, is at a Hold. Wright Medical Group N.V. (WMGI) has a 52-weeks low and high range of $19.04 and $30.66, respectively. It has a market capitalization of $2.92 billion.